Clinical trial
Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving…
NCT00022087 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00022087 |
|---|---|
| Title | Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer |
| Official title | Phase III Trial of Intravenous Zoledronic Acid (Zometa) in the Prevention of Bone Loss in Localized Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Osteoporosis |
| Intervention type | Dietary Supplement, Drug |
| Interventions | calcium salts, cholecalciferol, zoledronic acid |
| Enrollment | 439 |
| Start date | Dec 1, 2001 |
| Primary completion | Mar 1, 2007 |
| Completion | Feb 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 19, 2016 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: